Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
News|Slideshows|January 31, 2025
7 Drugs Approved for Primary Care: Q4 2024
Author(s)Sydney Jennings
An oral antibiotic for drug-resistant UTIs, a long-awaited therapy for congenital adrenal hyperplasia, and more.
Advertisement
The fourth quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US FDA for conditions that are often seen in primary care. In the slides above, find details on a new treatment for obstructive sleep apnea in patients with obesity, an oral antibiotic for drug-resistant urinary tract infections, a long-awaited therapy for congenital adrenal hyperplasia, and 4 more.
For more information on key FDA approvals from 2024, check out:
Advertisement
Related to this article
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.
The FDA accepted Organon’s MIUDELLA supplemental application, but the proposed change, supporting data, and review timeline remain undisclosed.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
2
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5